RBC raises target for Siemens Healthineers stock. It gains 1.76 percent.
Published on 10/16/2026 at 10:47 | Editorial responsibility: Rafael MĂŒller, Editor-in-Chief AD HOC NEWSAnalyst view and quarterly picture
- RBC raised its Siemens Healthineers target to EUR 48.00 on October 16, 2026.
- Third-quarter 2026 revenue rose 1.80 percent to EUR 5.76 billion.
- Siemens Healthineers stock trades at EUR 41.57 at 10:41 a.m. CEST at Lang & Schwarz on October 16, 2026, 1.76 percent above the Xetra close of October 15, 2026.
Siemens Healthineers (ISIN DE000SHL1006) traded at Lang & Schwarz at EUR 41.57 on October 16, 2026 at 10:41 a.m. CEST, up 1.76 percent versus the Xetra close of October 15, 2026 at EUR 40.85. BĂRSE ONLINE reported on October 16, 2026 that RBC raised its target from EUR 45.00 to EUR 48.00 while retaining an Outperform rating.
RBC lifts the target
RBC analyst Natalia Webster linked the higher target to the launch of Accela, a new radiotherapy system that the study said highlights Siemens Healthineers' clinical capabilities. The target is 15.47 percent above the Lang & Schwarz price, a calculation that places the analyst view above the current quotation.
The latest reported operating picture also gives the valuation debate a concrete base. Simply Wall St reported that third-quarter 2026 revenue reached EUR 5.76 billion, up 1.80 percent from the third quarter of 2025, while net income increased to EUR 669.0 million from EUR 553.0 million.
Three dated steps in the story
On August 4, 2026, Siemens Healthineers reported third-quarter revenue of EUR 5.76 billion and net income of EUR 669.0 million, according to Simply Wall St. On September 30, 2026, Jefferies kept a Buy rating and a EUR 50.00 target, as reported by Börse Express. On October 16, 2026, RBC raised its target from EUR 45.00 to EUR 48.00, according to BĂRSE ONLINE.
What dates matter next?
The next reporting date is November 5, 2026, when Siemens Healthineers plans to publish fourth-quarter results and hold its analyst call. The company lists a US roadshow for November 6, 2026. Both dates appear on the Siemens Healthineers investor relations page.
Stock price and valuation
The EUR 41.57 quotation sits below the EUR 48.00 RBC target but above the EUR 39.00 target retained by Deutsche Bank, which Börse Express reported on October 6, 2026. That 9.37-euro spread between the two targets shows why the November report is the next material test for the competing assessments.
Siemens Healthineers was trading at EUR 41.57 at Lang & Schwarz on October 16, 2026 at 10:41 a.m. CEST, 1.76 percent above the Xetra close of October 15, 2026 at EUR 40.85. The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.
Siemens Healthineers stock facts
- Company: Siemens Healthineers AG
- ISIN: DE000SHL1006
- WKN: SHL100
- Ticker: SHL
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 16, 2026, 10:41 a.m. CEST): EUR 41.57
- Change versus Xetra close: plus 1.76 percent
- Xetra close (October 15, 2026): EUR 40.85
- Market capitalization: EUR 46.5 billion (as of October 16, 2026)
- 52-week range: EUR 32.81-EUR 49.71 (as of October 16, 2026)
- Sector / Industry: Healthcare / Medical Devices
Market context: Market report DAX.
